FDA Approved: FRUZAQLA — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved FRUZAQLA (fruquintinib) from Takeda Pharmaceuticals America, Inc. as an original NDA approval for metastatic colorectal cancer after standard thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FRUZAQLA (fruquintinib)

Snippet

ORIG AP for FRUZAQLA (FRUQUINTINIB)